Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Children With Polyarticular Juvenile Rheumatoid Arthritis
jRCT2080220565Phase 3
- Sponsor
- Abbott Laboratories
- Start
- Jun 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of adalimumab in juvenile idiopathic arthritis (JIA), sponsored by Abbott Laboratories.
02
Drugs
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on jRCT2080220565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220565.